Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HPGDS | O60760 | 1/20 | 0.35 |
| ▸ | LDHA | P00338 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | BAZ2B | Q9UIF8 | 1/20 | 0.32 |
| ▸ | PTPN2 | P17706 | 1/20 | 0.31 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.31 |
| ▸ | TOP1 | P11387 | 1/20 | 0.31 |
| ▸ | CDK1 | P06493 | 1/20 | 0.30 |
| ▸ | CCNB1 | P14635 | 1/20 | 0.30 |
| ▸ | GSK3B | P49841 | 1/20 | 0.30 |
| ▸ | CDK5 | Q00535 | 1/20 | 0.30 |
| ▸ | CDK5R1 | Q15078 | 1/20 | 0.30 |
| ▸ | CA2 | P00918 | 1/20 | 0.30 |
| ▸ | CA4 | P22748 | 1/20 | 0.30 |
| ▸ | CA5A | P35218 | 1/20 | 0.30 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21503934 | 0.88 | LDHA (0.36) | HPGDSLDHALMNABAZ2BPTPN2 | |
| SCHEMBL18372163 | 0.85 | LMNA (0.40) | LMNATOP1CA2CA4CA5A | |
| SCHEMBL18372136 | 0.85 | LMNA (0.40) | LMNATOP1CA2CA4CA5A | |
| SCHEMBL18372115 | 0.85 | LMNA (0.40) | LMNATOP1CA2CA4CA5A | |
| SCHEMBL18253779 | 0.81 | GPR84 (0.32) | LMNA | |
| SCHEMBL18253854 | 0.80 | LMNA (0.34) | LMNATOP1CA2CA4CA5A | |
| SCHEMBL18253783 | 0.79 | LMNA (0.33) | LMNATOP1CA2CA4CA5A | |
| SCHEMBL20746673 | 0.78 | NPSR1 (0.38) | LMNATOP1NPSR1 | |
| SCHEMBL14076802 | 0.78 | LMNA (0.44) | LDHALMNABAZ2BPTPN2PTPN1 | |
| SCHEMBL22639305 | 0.78 | MEN1 (0.35) | LMNATOP1NPSR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10211404-B2 | Compound, material for organic electroluminescent elements, organic electroluminescent element and electronic device | IDEMITSU KOSAN CO., LTD. (JP) | 2019-02-19 | — | — | US | disclosed |
| US-20170012209-A1 | COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE | IDEMITSU KOSAN CO., LTD. (JP) | 2017-01-12 | — | — | US | disclosed |
| US-20170012209-A1 | COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE | IDEMITSU KOSAN CO., LTD. (JP) | 2017-01-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170012209-A1 | COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE | PIEZO1, TERT, TPR | HPGDS 3827/4885LDHA 715/4885LMNA 2224/4885 |
| US-10211404-B2 | Compound, material for organic electroluminescent elements, organic electroluminescent element and electronic device | PIEZO1, TERT, TPR | HPGDS 3827/4885LDHA 715/4885LMNA 2224/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.